Clinical trial
The Role of Lovaza® on Microvascular Function and Lipoprotein Profile in Type 2 Diabetes
NCT00931879 is registered in ClinicalTrials.gov with Eastern Virginia Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Lovaza® on Microvascular Function and Lipoprotein Profile in Type 2 Diabetes
- Lead sponsor
- Eastern Virginia Medical School
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- July 31, 2012
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic neuropathy, hypertriglyceridemia